Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bluejay Diagnostics Inc (BJDX)

Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,232
  • Shares Outstanding, K 1,814
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,720 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 0.62
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.34
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -118.16
  • Most Recent Earnings $-1.01 on 11/07/25
  • Next Earnings Date 03/30/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6325 +15.10%
on 12/29/25
1.3800 -47.25%
on 12/01/25
-0.5720 (-44.00%)
since 11/28/25
3-Month
0.6325 +15.10%
on 12/29/25
4.1700 -82.54%
on 10/09/25
-0.7920 (-52.11%)
since 09/30/25
52-Week
0.6325 +15.10%
on 12/29/25
10.2000 -92.86%
on 04/07/25
-3.1220 (-81.09%)
since 12/30/24

Most Recent Stories

More News
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal...

BJDX : 0.7280 (+7.22%)
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships

Company focused on advancing clinical milestones and strategic partnerships, with goal of positioning itself for future FDA clearance and product commercialization. Patient enrollment in SYMON-II clinical...

BJDX : 0.7280 (+7.22%)
Bluejay Diagnostics Raises $4M in Private Placement

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

BJDX : 0.7280 (+7.22%)
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical...

BJDX : 0.7280 (+7.22%)
Bluejay Diagnostics Expands Partnership with SanyoSeiko

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bluejay Diagnostics...

BJDX : 0.7280 (+7.22%)
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical...

BJDX : 0.7280 (+7.22%)
Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

ACTON, Mass. and YAMANASHI, Japan, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), a medical diagnostics company focused on developing rapid near-patient testing...

BJDX : 0.7280 (+7.22%)
Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

ACTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical...

BJDX : 0.7280 (+7.22%)
Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

BJDX : 0.7280 (+7.22%)
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

BJDX : 0.7280 (+7.22%)

Business Summary

Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass.

See More

Key Turning Points

3rd Resistance Point 0.8337
2nd Resistance Point 0.7813
1st Resistance Point 0.7547
Last Price 0.7280
1st Support Level 0.6757
2nd Support Level 0.6233
3rd Support Level 0.5967

See More

52-Week High 10.2000
Fibonacci 61.8% 6.5452
Fibonacci 50% 5.4162
Fibonacci 38.2% 4.2873
Last Price 0.7280
52-Week Low 0.6325

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar